MiR-139-5p Targetedly Regulates YAF2 and Mediates the AKT/P38 MAPK Signaling Pathway to Alleviate the Metastasis of Non-Small Cell Lung Cancer Cells and Their Resistance Against Cisplatin

MiR-139-5p Targetedly Regulates YAF2 and Mediates the AKT/P38 MAPK Signaling Pathway to Alleviate the Metastasis of Non-Small Cell Lung Cancer Cells and Their Resistance Against Cisplatin

Yubo Yan, Xiangyuan Jin, HaoBo Sun, Sainan Pang, Xianglong Kong, Jianlong Bu, Shidong Xu Department of Thoracic Surgery, Harbin Medical University Tumer Hospital, Harbin, Heilongjiang Province, 150000, People’s Republic of ChinaCorrespondence: Shidong XuDepartment of Thoracic Surgery, Harb...

Full description

Bibliographic Details
Main Authors: Yan Y, Jin X, Sun H, Pang S, Kong X, Bu J, Xu S
Format: Article
Language:English
Published: Dove Medical Press 2021-05-01
Series:Cancer Management and Research
Subjects:
mir-139-5p
yaf2
akt / p38 mapk
non-small cell lung cancer
cisplatin
Online Access:https://www.dovepress.com/mir-139-5p-targetedly-regulates-yaf2-and-mediates-the-aktp38-mapk-sign-peer-reviewed-fulltext-article-CMAR

Internet

https://www.dovepress.com/mir-139-5p-targetedly-regulates-yaf2-and-mediates-the-aktp38-mapk-sign-peer-reviewed-fulltext-article-CMAR

Similar Items